Featuring one-on-one discussions with leading oncology investigators, this series assists clinicians with the formulation of up-to-date clinical management stra...
Oncology Today with Dr Neil Love: Optimizing the Management of Tenosynovial Giant Cell Tumor
Dr Emanuela Palmerini from the IRCCS Istituto Ortopedico Rizzoli in Bologna, Italy, discusses the current and future clinical treatment of tenosynovial giant cell tumor.
--------
1:03:55
Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma
Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging treatment strategies for dedifferentiated liposarcoma and other sarcomas.
--------
1:15:13
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
Dr Evan J Lipson from the Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland, summarizes major clinical advances over the past year for treating skin cancers.
--------
59:36
Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review
Dr Nikhil I Khushalani from Moffitt Cancer Center in Tampa, Florida and Dr Jason J Luke from UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania discuss recently presented findings from ASCO on the management of melanoma and nonmelanoma skin cancers.
--------
1:06:09
Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer
Dr Nikhil Khushalani from the Moffitt Cancer Center in Tampa, Florida, and Dr Anna Pavlick from the Weill Cornell Medicine Meyer Cancer Center in New York, New York, discuss available and novel treatment strategies for cutaneous squamous cell carcinoma and basal cell carcinoma.
Featuring one-on-one discussions with leading oncology investigators, this series assists clinicians with the formulation of up-to-date clinical management strategies so that they can provide optimal care for patients with melanoma and nonmelanoma skin cancer.